with the advance of biochemistry, digital/structure, and wide arrays of CRO steps from screening to pre-clinical efficacy becomes straight forward. The bottle neck seems to be the first step: target selection. Too few disease-drivers which attract huge crowd!
with the advance of biochemistry, digital/structure, and wide arrays of CRO steps from screening to pre-clinical efficacy becomes straight forward. The bottle neck seems to be the first step: target selection. Too few disease-drivers which attract huge crowd!